EEG / EMG in New York

Cognivue manufactures FDA-cleared digital cognitive assessment devices for early detection of cognitive impairment. The company's proprietary adaptive psychophysics technology collects 130,000 data points per assessment, delivering self-administered computerized evaluations customized to each patient's visual and motor skills. The platform removes bias inherent in traditional cognitive assessment tools and provides standardized testing across diverse healthcare settings. Cognivue offers two primary product lines: Cognivue Clarity®, a 10-minute comprehensive assessment evaluating four cognitive domains (memory, executive function/attention, discrimination, visuospatial) plus two performance parameters; and Cognivue Thrive®, a 5-minute abbreviated screening tool assessing three cognitive domains (memory, visuospatial, executive function). Both devices are validated against gold-standard assessment tools such as Montreal Cognitive Assessment (MoCA) and St. Louis University Mental Status (SLUMS) examination, demonstrating superior test-retest reliability and high sensitivity for detecting mild cognitive impairment. The company markets its assessment platform to physicians, hearing healthcare providers, and pharmacies. Clinical data demonstrates Cognivue's effectiveness as an adjunctive tool for cognitive function evaluation in primary care, geriatric, audiology, and pharmacy settings. Cognivue also offers Cogniwell®, a patient-facing lifestyle program complementing clinical assessment. The devices are indicated as adjunctive tools and require licensed clinician interpretation; they do not function as standalone diagnostic instruments. Cognivue is headquartered in Victor, NY, and maintains FDA 510(k) clearance for its technology platform.

Netech Corporation is a US-based manufacturer of biomedical test equipment and patient simulators for medical device validation and clinical training. Founded over 33 years ago, the company specializes in portable, easy-to-use testing instruments designed for hospital clinical engineering, biomedical maintenance, device manufacturers, and training institutions. Product categories include patient simulators (ECG, EEG, SpO2, pacemaker), defibrillator analyzers, infusion pump analyzers, electrical safety analyzers, pressure meters, and gas flow meters. The MiniSim product line offers compact, modular waveform generators for testing cardiac monitors, EEG recorders, and multi-parameter patient monitoring systems. The EXPMT 2000 External Pacemaker Analyzer is designed for atrial, ventricular, and transcutaneous pacemaker testing. All products are manufactured in the USA. Netech serves clinical engineering departments, biomedical equipment manufacturers, healthcare training centers, and medical device testing laboratories. The company emphasizes quality, reliability, and value in regulatory and performance testing workflows. Equipment is used for device validation, preventive maintenance, troubleshooting, and competency-based training. Netech's offerings support compliance with medical device testing standards and clinical engineering protocols.

Evoke by Firefly Neuro (formerly Evoke Neuroscience) is a healthcare technology company specializing in computational EEG (electroencephalography) systems for objective brain health assessment and early diagnosis of cognitive impairment. The company's flagship product, the evoke® Brain Health System, is an FDA-cleared Class II medical device that uses quantitative EEG (qEEG) and event-related potential (ERP) recordings to evaluate neurophysiology biomarkers in clinical settings. The system enables primary care and specialty physicians to assess cognitive function in-office in under one hour, helping identify treatable conditions such as dementia, memory loss, depression, and ADHD. With over 191,000 assessments performed and 2 billion data points collected, Evoke serves healthcare providers and pharmaceutical companies in CNS drug development. The company provides hardware, software, clinician training, and ongoing clinical education to facilitate integration into existing practices.

DIXI Medical is a specialized neurosurgical device manufacturer with over 50 years of expertise in stereotactic electroencephalography (SEEG) systems and functional neurosurgery. The company develops high-precision intracerebral electrodes, intraoperative neurophysiological monitoring systems, and stereotactic implantation accessories for epilepsy diagnosis, treatment, and brain research applications. Core product lines include MICRODEEP® SEEG electrodes (sterile, single-use with up to 18 contacts and 0.8 mm diameter for deep brain exploration and thermocoagulation), MICRODEEP® Micro-Macro electrodes (for simultaneous multi-scale neuronal recording bridging clinical and research use), and Cortical IOM electrodes for intraoperative real-time cortical monitoring and stimulation. The company also manufactures dedicated stereotactic implantation instruments and accessories. DIXI Medical serves epilepsy centers and functional neurosurgery programs in over 40 countries and supports SEEG training and research initiatives globally. Manufacturing capabilities include microtechnical precision engineering, sterilization, and quality assurance aligned with medical device standards. The company emphasizes clinical collaboration with neurosurgeons, neurologists, and researchers, with field-based clinical support teams and ongoing investment in training programs for healthcare professionals. Products are designed for compatibility with robotic stereotactic systems and are used in both surgical and research settings.

Anschel Technology Inc. manufactures the SightSaver™, an FDA-approved and patented device for eliciting visual evoked potentials (VEPs) during intraoperative monitoring. The device is designed to prevent post-operative visual loss (POVL)—a serious complication affecting several thousand patients annually in the United States following non-ocular surgical procedures such as spine surgery. The SightSaver™ addresses critical gaps in existing visual stimulation approaches by providing a hygienic, safe, comfortable, and reliable alternative to low-quality, non-hygienic, and unreliable legacy stimulators. The company was founded in 2011 by Dr. David Anschel, a board-certified neurologist and clinical neurophysiologist with extensive academic credentials and research background. The SightSaver products enable perioperative vision risk management through real-time intraoperative visual monitoring, supporting surgical teams in detecting and mitigating vision loss during high-risk procedures.

BioSignal is a neurodiagnostic company specializing in functional brain assessment via portable EEG technology. The company's FDA-approved microEEG® solution is a miniature, wireless clinical platform enabling rapid electroencephalogram (EEG) recording with cloud-based remote interpretation. BioSignal serves traditional neurology settings (epilepsy centers, sleep labs, neurology departments, ICUs) and expands brain function assessment into novel environments including emergency departments, NICUs, physician offices, ambulances, and home care. The platform supports sports concussion management, traumatic brain injury assessment, routine EEG monitoring, and STAT EEG capabilities. Applications span clinical neurology, emergency medicine, pediatric critical care, sleep medicine, sports medicine, and home sleep monitoring. The solution combines hardware portability with interpretive software to enable rapid assessment and telemedicine-capable EEG interpretation.